NCT01865942

Surgical Spinal Decompression of Metastatic Spinal Cord Compression, Minimal Access Versus Open Surgery

Completed NA Last updated 4 April 2017

What this trial tests

NA trial testing open surgery in Spinal Metastases in 50 participants. Completed in 30 March 2017.

Timeline

28 August 2014

Primary endpoint
2 January 2017

30 March 2017

Quick facts

Lead sponsor	Rigshospitalet, Denmark
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	none
Primary purpose	treatment
Enrollment	50
Start date	28 August 2014
Primary completion	2 January 2017
Estimated completion	30 March 2017
Sites	1 location across Denmark

Drugs / interventions tested

• open surgery
• Minimal access surgery

Conditions studied

• Spinal Metastases — all drugs for Spinal Metastases →

Sponsor

Rigshospitalet, Denmark

Who can join

Adults 18 to 99, any sex, with Spinal Metastases. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The investigators wish to evaluate the effect of minimal access spinal surgery compared to traditional open surgery spinal surgery in patients with metastatic spinal cord compression.

Minimal access surgery has been shown to bee less damaging for the tissue compared to traditional open surgery and also cause fewer wound complications, the investigators expect the above could have impact in a vulnerable patient group like patients with metastatic spinal cord compression.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

1. Recent advances and new discoveries in the pipeline of the treatment of primary spinal tumors and spinal metastases: a scoping review of registered clinical studies from 2000 to 2020.
   Furlan JC, Wilson JR, Massicotte EM, Sahgal A, et al · · 2022 · cited 24× · PMID 34508647 · DOI 10.1093/neuonc/noab214